Skip to main content

Table 1 Subject characteristics

From: Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Patient characteristics

n (%)

Age, mean ± SD (year)

50.9 ± 11.5

Male, n (%)

238 (85.0%)

Diabetes, n (%)

22 (7.9%)

Hypertension, n (%)

53 (18.9%)

 Background liver disease

  HB

176

  HC

8

  HB and HC

2

  Non-B non-C

94

ASA grading, mean + SD

2.3 ± 0.6

Hemoglobin, mean ± SD (g/dL)

130.7 ± 19.7

White blood cell count, mean ± SD (109/L)

5.5 ± 2.5

Platelet count, mean ± SD (109/L)

135.8 ± 71.0

Total bilirubin, mean ± SD (μmol/L)

24.4 ± 45.7

ALT, mean ± SD (U/L)

54.2 ± 57.1

AST, mean ± SD (U/L)

56.8 ± 63.2

INR, mean ± SD

1.08 ± 0.1

Albumin, mean ± SD (g/L)

39.1 ± 5.5

GP73, mean ± SD (ng/mL)

111.8 ± 153.3

Child–Pugh score, mean ± SD

5.6 ± 1.0

Child–Pugh grade (A/B/C)

262/18/0

Size of largest tumor, mean ± SD (cm)

6.2 ± 3.6

Solitary tumor, n (%)

246 (87.9%)

Blood loss, mean ± SD (min)

805.8 ± 961.8

Intermittent hilar clamping, mean ± SD (min)

14.3 ± 15.2

Operation time, mean ± SD (min)

233.5 ± 200.2

Intraoperative procedures

 Minor hepatectomy

199

 Major hepatectomy

81

Clavien–Dindo classification

 Grade 1

35

 Grade 2

81

 Grade 3a/3b

19/1

 Grade 4a/4b

5/0

 Grade 5

4

  1. AST aspartate aminotransferase, ALT alanine aminotransferase, ASA American Society of Anesthesiology, HBV hepatitis B virus, HCV hepatitis C virus